A number of studies have showed that IL-10 reduces the synthesis level of VEGF, TNF-α, or MMP-9, which leads to a prevention of angiogenesis associated with the growth of the tumour; such as melanoma and prostate cancer [41, 42]. Here, IL10 is linked to prostate cancer.